Campbell & CO Investment Adviser LLC Intercept Pharmaceuticals, Inc. Transaction History

Campbell & CO Investment Adviser LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$12.21 - $19.7 $599,779 - $967,703	49,122 New	49,122 $685,000
Q3 2021 Nov 10, 2021	SELL	$12.99 - $20.47 $494,061 - $778,555	-38,034 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$15.46 - $24.5 $588,005 - $931,833	38,034 New	38,034 $760,000
Q3 2019 Oct 16, 2019	SELL	$58.69 - $80.46 $303,662 - $416,300	-5,174 Closed	0 $0
Q2 2019 Jul 10, 2019	BUY	$77.77 - $120.68 $402,381 - $624,398	5,174 New	5,174 $412,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.